Skip to content

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice: a Prospective Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094015
Acronym
HISTEROS-07
Enrollment
92
Registered
2010-03-26
Start date
2007-07-31
Completion date
2009-04-30
Last updated
2010-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

hysteroscopy, local anaesthetic, pain relief, gynecological pathology

Brief summary

The purpose of this study is to demonstrate that Lidocaine-Prilocaine cream decrease pain during hysteroscopy diagnostic practice.

Interventions

Implementation of 3 cm of lidocaine-prilocaine in the endocervical canal, 10 minutes before the intervention with a syringe without needle 5ml. Application, with a swab of the anesthetic cream ectocervix level.

OTHERgel application for the transmission of ultrasound

3 cm of gel application for the transmission of ultrasound into the endocervical canal 10 minutes before surgery, with a 5ml syringe without needle. Application, with a swab in gel ectocervix

Sponsors

Consorci Sanitari de Terrassa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients that he must perform a diagnostic hysteroscopy * acceptance to participate in the study signed informed consent

Exclusion criteria

prerandomization: * hypersensitivity or allergy to anesthetics * refusal of the patient * patients under age 18 and pregnant

Design outcomes

Primary

MeasureTime frameDescription
pain reduction in the performance of hysteroscopyafter hysteroscopy and a month laterdecrease in pain immediately after the completion of hysteroscopy and one month after completion of the diagnostic test by an analogue pain scale

Secondary

MeasureTime frameDescription
sense of discomfort experience during the procedurea month after hysteroscopywillingness to repeat the diagnostic technique

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026